Hair Fall in Patients on Low Dose Methotrexate

Launched by COLUMBIA ASIA · Oct 29, 2015

Keywords

ClinConnect Summary

No description provided

Gender

ALL

Eligibility criteria

• Inclusion Criteria:
• • For Cases
• • Subjects should be above 18 years of age.
• • Diagnosed with rheumatoid arthritis and fulfilling the ACR EULAR 2010 criteria.
• • Should be initiated on methotrexate
• • Willing to follow up
• • For Controls
• • -Subjects should be above 18 years of age.
• Exclusion Criteria:
• • For Cases
• • Subjects with prior exposure to methotrexate in the last 6 months
• • Subjects suffering from Thyroid (hypothyroidism)
• • Subjects on leflunomide, or having received leflunomide in the last 6 months
• • Subjects currently on cyclophosphamide or having received cyclophosphamide in the last 3 months.
• • Subjects on psychiatric treatment or depression illness.
• • Subjects who have overlap with other rheumatological disorders which can cause hair fall.
• • Subjects in 1-5 months of post-partum or post-natal period.
• • Subjects with female pattern baldness
• • Subjects with androgenetic alopecia
• • Subjects with alopecia aereta
• • Subjects with other scalp conditions which can predispose to hair fall
• • For Controls
• • Subjects having any family history of alopecia.
• • Subjects suffering from thyroid.
• • Subjects having any history of anemia.
• • Subjects under 1-5 months of post-partum or post-natal period.
• • Subjects on medications which can cause hair fall.
• • Subjects on methotrexate for other reasons.
• • Subjects with female pattern baldness
• • Subjects with androgenetic alopecia
• • Subjects with alopecia aereta
• • Subjects with other scalp conditions which can predispose to hair fall